Bipolar disorder

...ba href=/bipolar disorder/a/b.

Source: China Daily Comment on the story Tell a friend Print friendly format Save this Recommendation - Text Version - RSS Feeds - China Forum - Newsletter - People's Comment - Most Popular Related News Alibaba Directory Alibaba China China Suppliers Copyright by People's Daily Online, all rights reserved ...

...ba href=/bipolar disorder/a/b, adolescent depression and schizophrenia, funded by NIMH.

This comparative research is different from that conducted by private companies.

It is an essential building block for a public research and treatment 'infrastructure' that can lead to newer, better medications.

It is essential that Congress continue funding NIMH so that NIMH can continue funding such studies, to keep the momentum going.

* The importance of switching or adding medications underscores the importance of preserving broad access to a range of medications.

Governors and state legislatures must now reconsider restricted formularies in Medicaid programs.

Employers should review restrictions under managed care plans.

Limiting choices to only two or three antidepressants condemns too many individuals to life-threatening illness.

* Additional research is still needed.

These studies did not directly compare the effectiveness of switching medication to adding one.

We also need better understanding of psychosocial forces surrounding depression and the relative effectiveness of psychotherapy, particularly in combination with different medications." See also http://www.nimh.nih.gov/press/stard2.cfm SOURCE NAMI Web Site: http://www.nami.orghttp://www.nimh.nih.gov/press/stard2.cfm Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.Terms and conditions, including restrictions on redistribution, apply.

Copyright © 1996- PR Newswire Association L...

... ABC12.com: TM for ADHD #navigation ul#primaryNav li#primaryNav2 {color: #fff; background-image: url('http://abclocal.go.com/graphics/v3/wjrt/WJRTactiveTab.gif');} HOMENEWSWEATHERSPORTSRESOURCESFEATURESON ABC12AUTOJOBS Oddities Bizarre News EntertainmentHealth HealthFirstHealthology LocalNation & WorldstateConsumerTech SkycamAnimated Radar baseballbasketballfootballhockeynascarsoccer AutomotiveHoroscopesLegal pagesLotteryTrafficSite Mapabc12 Message BoardsCoupon Bug HomeWorkcommunity Monday's ChildNotebookConnect With Kids On the TrailMr.

Food ABC12 Recipes Travel TV ListingsStation Info abc12 News TeamContact Usabc12 and HDTV Message BoardsNotebookSite Mapabc12 Message BoardsMr.

Food Monsterabc12 Jobs TEXT SIZE: A A A A Site Search site web HealthFirst-TM for ADHD By Leslie LoBue (03/23/06)- In a surprise decision, an FDA panel will not recommend a black box warning label about potential cardiovascular and psychiatric risks associated with some drugs used to treat Attention Deficit Hyperactivity Disorder.

That goes against the advice of another committee that voted last month to include the labels on some ADHD drugs.

This latest decision does call for more clear language to describe the potential risks on drug labels.

Some schools are taking an extremely simple approach to help kids focus and learn and it is having a big impact.

It's not the typical scene at an American middle school.

The kids, all with ADHD, are practicing transcendental meditat...